Aspire Biopharma Holdings, Inc. (ASBP) Stock

Consumer Cyclical · Auto Parts · Member of Other US Stocks

Aspire Biopharma Holdings, Inc. (ASBP) closed at USD 8.16 on 2026-10-14, a change of -54.2 % over the past year, with a market capitalization of USD 12.12M.

Aspire Biopharma Holdings, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Aspire Biopharma Holdings, Inc. key figures

Previous close

USD 8.16 (2026-10-14)

1-year change

-54.2 %

Market cap

USD 12.12M

Enterprise value

USD -49,041

P/E ratio (trailing)

-0.28

P/E ratio (forward)

n/a

EPS (trailing)

-30.97

EPS (forward)

n/a

PEG ratio

n/a

Price to book

0.95

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.37

Employees

n/a

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Aspire Biopharma Holdings, Inc.

Aspire-Lakewood Holdings, Inc. develops sublingual drug delivery technology and manufactures automotive and industrial control systems. The company develops a nano-technology-based sublingual drug delivery system designed to enhance the pharmacokinetic performance of active pharmaceutical ingredients, supplements, and nutraceuticals to increase bioavailability, improve speed of onset, and reduce side effects. Its lead prescription product candidate, Sublingual High Dose Aspirin, targets pain management and anti-inflammatory applications. The company also develops Alprazolam in a sublingual formulation for anxiety treatment and offers Buzz Bomb Caffeine, a sublingually administered caffeine pre-workout consumer supplement. Additionally, it develops sublingual formulations of Melatonin for sleep aid, Sublingual ED for erectile dysfunction, testosterone products, and vitamins D, E, and K. The company targets therapeutic applications including heart attack and stroke, anxiety, antiplatelet conditions, nausea, pain management, and inflammation. The company also designs and manufactures engineered control systems that integrate mechanical engineering, electronics, and computer science for body, chassis, powertrain, electrical, and interior vehicle applications. It offers HMI and actuation systems, safety systems, shift systems, pedal systems, park systems, mechanical control cables, and mechatronic systems. Aspire-Lakewood Holdings, Inc. was formerly known as Aspire Biopharma Holdings, Inc. and changed its name to Aspire-Lakewood Holdings, Inc. in September 2026. Aspire-Lakewood Holdings, Inc. was incorporated in 2021 and is based in Estero, Florida.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Aspire Biopharma Holdings, Inc. and compare it with other stocks.